Panos Gikas is a renowned orthopedic surgeon in London. Upon completion of the medical and postgraduate training in London, Mr. Gikas specialized in knee cartilage injuries, primary and revision hip, and the overall surgical management of the primary and metastatic bone cancer.
However, his journey began when he completed the Seddon Travelling Fellowship in the field of orthopedic oncology. The training was based at the Royal Alfred Hospital in Sydney.
Panos Gikas further concentrated on the specialist skills in the management of bone tumors. Among his accolades includes the completion of the clinical fellowship hosted in Geneva. It was here that he developed the use of the anterior muscle sparing technique to the hip joint. Afterward, he embarked on a consultant post at the celebrate Royal National Orthopedic Hospital.
Most of his research and clinical endeavors have revolved around the hip and knee reconstruction with the treatment of bone and soft tissue cancer. Among his major works includes the presentation and publishing of the different aspects of the hip, bone and knee cancer surgery.
Mr. Gikas is also a frontrunner in the field of leadership research and the laboratory research. Some of his other hobbies include traveling, water skiing, and sailing. He also is a master of the Greek language.
The passion and commitment of Panos Gikas have been crucial in the clinical research concerning the orthopedic surgery. It is in the same field that holds a master’s degree and doctorate. His commitment to the field of research has landed him various grants as highlighted here https://stfc.ukri.org/news/first-human-trials-show-non-invasive-diagnosis-of-bone-diseases-possible/. Throughout his career, he has also won a couple of the highly-coveted academic prizes.
Among his published works that have made an impact include the 7 book chapters and close to 30 peer-reviewed research works. Some of the research works he carried out has been integrated into the national guidelines for the management of the cartilage and the defects of the knee joint. See more here.
Panos Gikas is a board member at the Specialty Register of General Medical Council. He is also a member of the Royal College of Surgeons of England. Among other orthopedic organizations and associations he is affiliated to includes; The Royal Society of Medicine, European Musculo-Skeletal Oncology Society, International Society of Limb Salvage and the British Orthopedic Oncology Society.
Marc Beer has taken the fight against pelvic floor disorders to the next level by securing financing for his women health startup, Renovia, Inc. He successfully raised $42 million in venture debt and Series B round. The women health startup now is set to move forward with development of four main products including the new generation of the Leva device. Renovia is a pharmaceutical company that is committed to improve the lives of women living with pelvic floor disorders around the world.
According to a research, urinary incontinence affects over 250 million women across the world. Mr. Marc Beer’s company has been dedicated to developing diagnostic and therapeutic products to treat the disorders. Since inception, the company has made incredible progress with some of its products receiving FDA approval. The company’s Leva device received FDA approval in April this year.
He raised $32 million in Series B round and $10 million in venture debt. Big players in the healthcare industry participated in Series B round conducted by the New York-based Perceptive Advisors and Missouri-based Ascension Ventures. The funding will boost the company’s efforts significantly with the development of the four pelvic floor disorder treatment products.
Marc Beer was excited by the move of the players in the industry to support him in his fight against the disorders. He has so far received unwavering support from the leading investors in the healthcare industry. He said in a statement that the investors shares his vision of improving the lives of women across the world who are suffering from pelvic floor disorders. Using cutting edge technology and solutions, he aims to make valuable data accessible to customers. The data generated will inform better pelvic floor disorder treatment options, build on the existing knowledge and eventually, promote the understanding of the disorders. The efforts are directed towards reduce healthcare costs in the long-run. Learn more: https://renoviainc.com/leadership/
The renowned healthcare entrepreneur has led a noble career in the industry. He was a strategic consultant in OvaScience, a pharmaceutical company which later merged with Millendo Therapeutics. Marc Beer is the CEO as well as Co-founder of Renovia, a Boston-based medtech company. He has over 25 years of experience in the industry with a specialty on development and commercialization in biotechnology, pharmaceutical, diagnostic as well as device industries. He a BS graduate from Miami University, OHIO.
He founded ViaCell and established it over time to have over 300 employees and later, go public. The company was acquired in 2007 by PerkinElmer. He is also a member of the board of directors of Erytech Pharmaceuticals. Marc Beer is also the Founding Chairman of committee of Good Start Genetics’ board of directors. He also holds prestigious positions in Minerva Neurosciences. He is also a member of Miami University Business Advisory Council. He served in other prestigious positions.
Building a band is not something that is easy. Finding the right people to be in the band isn’t either. For Andrew Taggart however, when the first member of the Chainsmokers left, he wanted to move forward by bringing someone else in. This was the best thing that he could have ever done. It opened up for a whole new friendship to occur between him and Alex Pall.
Using social media has allowed for bands and fans to be able to communicate with one another. Bands are able to see what their fans are really up to and what age bracket that they see those fans in. The Chainsmokers have been able to see what ages their fans are and to see messages from fans that allow them to peek inside of their fans lives. One woman wrote to them to tell them about her mother singing along and humming to one of their songs. This was something that had social media never happened, they would not have known about. Even the small things matter to the band.
The Chainsmokers have started to see a difference in the people attending their shows. The audience members were once a set age bracket and since they have started to release new music unlike anything that they had ever released, there are now even more people attending their shows of all age brackets. The original followers are still present and accounted for however the number of new fans is always growing which is making their shows even more packed than ever before.
Andrew Taggart and Alex Pall know how to put on a show and have been able to do things for their fans that they never thought they would have. One thing that they have begun doing is singing for their fans. Andrew took to his vocals to sing lead on the song “Closer” which was something that created a new level of playing for bands that they never thought they could have competed against. With each new change, the band has been able to reach the top of the charts and have been able to hold onto their spot because of the music they keep releasing.
Andrew Taggart is an original member of the band The Chainsmokers and when his counterpart opted to leave, there left an opening. That is when Alex Pall and him met. In that moment, the two spent some time learning about each other and found that they would be perfect to continue the band on. That simple thought has led them to becoming a top chart selling performer of all time. They have been lucky enough to climb the charts and to stay there.